(Q90384448)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569768%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

title

Identification of New DR5 Agonistic Nanobodies and Generation of Multivalent Nanobody Constructs for Cancer Treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569768%20AND%20SRC:MED&resulttype=core&format=json

Robert Alvin Bernedo Navarro

13 April 2020

author

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569768%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Serge Muyldermans

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569768%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

author name string

Golnaz Sadeghnezhad

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569768%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Ema Romão

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569768%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Sam Massa

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569768%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Khosro Khajeh

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569768%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

Sadegh Hassania

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569768%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

publication date

27 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569768%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Molecular Sciences

13 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569768%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569768%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

issue

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569768%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

13 April 2020

copyright license

start time

27 September 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli

1 reference

12 December 2020

Naturally occurring antibodies devoid of light chains

1 reference

12 December 2020

A novel receptor for Apo2L/TRAIL contains a truncated death domain

1 reference

12 December 2020

Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway

1 reference

12 December 2020

Molecular cloning and functional analysis of the mouse homologue of the KILLER/DR5 tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) death receptor.

1 reference

12 December 2020

Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation

1 reference

12 December 2020

Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5

1 reference

12 December 2020

A unique zinc-binding site revealed by a high-resolution X-ray structure of homotrimeric Apo2L/TRAIL

1 reference

12 December 2020

Crystal structure of TRAIL-DR5 complex identifies a critical role of the unique frame insertion in conferring recognition specificity

1 reference

12 December 2020

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

1 reference

12 December 2020

Targeting the extrinsic apoptosis pathway in cancer

1 reference

12 December 2020

Nanobodies: natural single-domain antibodies

1 reference

12 December 2020

Structure of human cytomegalovirus UL141 binding to TRAIL-R2 reveals novel, non-canonical death receptor interactions

1 reference

12 December 2020

APG350 induces superior clustering of TRAIL receptors and shows therapeutic antitumor efficacy independent of cross-linking via Fcγ receptors

1 reference

12 December 2020

Design and characterization of structured protein linkers with differing flexibilities

1 reference

12 December 2020

Multivalent nanobodies targeting death receptor 5 elicit superior tumor cell killing through efficient caspase induction

1 reference

12 December 2020

Apoptosis: A Target for Anticancer Therapy

1 reference

12 December 2020

Structural Basis for the Specific Neutralization of Stx2a with a Camelid Single Domain Antibody Fragment.

1 reference

12 December 2020

Structural insights into the mechanism of action of a biparatopic anti-HER2 antibody.

1 reference

12 December 2020

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

1 reference

12 December 2020

Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium

1 reference

12 December 2020

Higher-Order Clustering of the Transmembrane Anchor of DR5 Drives Signaling

1 reference

12 December 2020

A New Efficient Method for Production of Recombinant Antitumor Cytokine TRAIL and Its Receptor-Selective Variant DR5-B

1 reference

12 December 2020

Identifiers

DOI

10.3390/IJMS20194818

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569768%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31569768%20AND%20SRC:MED&resulttype=core&format=json

13 April 2020

1 reference